oxazoles has been researched along with Panic Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gimbrett, R; Priest, RG; Roberts, M; Steinert, J | 1 |
| Arancio, C; Bellodi, L; Bertani, A; Cocchi, S; Perna, G | 1 |
| Griebel, G; Perrault, G; Sanger, DJ | 1 |
1 trial(s) available for oxazoles and Panic Disorder
| Article | Year |
|---|---|
Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study.
Topics: Administration, Inhalation; Administration, Oral; Adult; Agoraphobia; Antidepressive Agents; Arousal; Carbon Dioxide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Oxazoles; Oxazolidinones; Panic; Panic Disorder; Single-Blind Method | 1994 |
2 other study(ies) available for oxazoles and Panic Disorder
| Article | Year |
|---|---|
Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Topics: Alzheimer Disease; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Benzamides; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Panic Disorder; Phobic Disorders; Piperidines | 1995 |
Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs.
Topics: Animals; Anxiety; Avoidance Learning; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Panic Disorder; Rats | 1997 |